Concepedia

Therapeutic drug monitoring guides the management of patients with chronic non-infectious uveitis treated with adalimumab: a retrospective study

Lucas Séjournet, Sébastien Kerever, Thibaud Mathis, Laurent Kodjikian, Yvan Jamilloux, P. Sève

British Journal of Ophthalmology · 2021 · 22 citations · 14 references

DOI

Abstract

TDM of ADA treatment proved relevant to provide CNIU patients with a personalised and optimised treatment course (in terms of frequency and type of drug).

References

14

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 2.2K citations

, , +7

Adalimumab in Patients with Active Noninfectious Uveitis

Glenn J. Jaffe, Andrew D. Dick, Antoine P. Brézin et al. · New England Journal of Medicine · 2016 · 633 citations · Full text

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease

Séverine Vermeire, M. Noman, Gert Van Assche et al. · Gut · 2007 · 599 citations · Full text

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

Quan Dong Nguyen, Pauline T. Merrill, Glenn J. Jaffe et al. · The Lancet · 2016 · 483 citations · Full text

, , +8

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

Niels Vande Casteele, Ann Gils, Sharat Singh et al. · The American Journal of Gastroenterology · 2013 · 342 citations